相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Action plan for hit identification (APHID): KAT6A as a case study
Xiangyan Yi et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents
Daniel L. Priebbenow et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
HBO1 is required for the maintenance of leukaemia stem cells
Laura MacPherson et al.
NATURE (2020)
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A
David J. Leaver et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
Jonathan B. Baell et al.
NATURE (2018)
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
Jayme L. Dahlin et al.
NATURE COMMUNICATIONS (2017)
Histone acetyltransferase inhibitors: where art thou?
Jonathan B. Baell et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
Jonathan B. Baell
JOURNAL OF NATURAL PRODUCTS (2016)
Tetrabenazine: Spotlight on Drug Review
Navneet Kaur et al.
ANNALS OF NEUROSCIENCES (2016)
Ligand efficiency metrics: why all the fuss?
Charles H. Reynolds
FUTURE MEDICINAL CHEMISTRY (2015)
Screening-Based Translation of Public Research Encounters Painful Problems
Jonathan B. Baell
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
The discovery of first-in-class drugs: origins and evolution
Joerg Eder et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350,000 Compounds
Jonathan B. Baell
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-X-L
Brad E. Sleebs et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Ron O. Dror et al.
NATURE (2013)
Structure-guided design of a selective BCL-XL inhibitor
Guillaume Lessene et al.
NATURE CHEMICAL BIOLOGY (2013)
Observations on screening-based research and some concerning trends in the literature
Jonathan B. Baell
FUTURE MEDICINAL CHEMISTRY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Inhibition of destructive autoimmune arthritis in Fc gamma RIIa transgenic mice by small chemical entities
Geoffrey A. Pietersz et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Characterization of the Two Fundamental Conformations of Benzoylureas and Elucidation of the Factors That Facilitate Their Conformational Interchange
Guillaume Lessene et al.
JOURNAL OF ORGANIC CHEMISTRY (2009)
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
Hiroshi Hirai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Tetrabenazine
Michael R. Hayden et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Phosphate isosteres in medicinal chemistry
CS Rye et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3:: Synthesis and immunosuppressive activity
JB Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Design and synthesis of type-III mimetics of ShK toxin
JB Baell et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2002)
分享论文
